We are live on ! Find out more
CA

Callahan Advisors Portfolio holdings

AUM $1.33B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+12.43%
1 Year Est. Return
+29.71%
3 Year Est. Return
+87.75%
5 Year Est. Return
+121.89%
10 Year Est. Return
+408.77%
AUM
$891M
AUM Growth
+$97.8M
Cap. Flow
+$10.2M
Cap. Flow %
1.14%
Top 10 Hldgs %
29.98%
Holding
153
New
7
Increased
75
Reduced
46
Closed
5

Top Buys

Rank Stock Value
1
DHI icon
D.R. Horton
DHI
+$2.2M
2
PARA
Paramount Global Class B
PARA
+$1.85M
3
PFE icon
Pfizer
PFE
+$1.84M
4
FDX icon
FedEx
FDX
+$1.32M
5
EXP icon
Eagle Materials
EXP
+$1.25M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.75M
2
T icon
AT&T
T
+$1.67M
3
FTNT icon
Fortinet
FTNT
+$1.51M
4
BUD
ANHEUSER BUSCH COS INC
BUD
+$1.33M
5
FICO icon
Fair Isaac
FICO
+$1.05M

Sector Composition

Rank Sector Weight
1 Technology 18.55%
2 Healthcare 16.63%
3 Consumer Discretionary 11.81%
4 Financials 10.81%
5 Communication Services 9.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.46T
$39.9M 4.47%
224,459
-4,187
-2% -$662K
MSFT icon
2
Microsoft
MSFT
$3.62T
$38.7M 4.34%
115,126
-634
-0.5% -$206K
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.56T
$33.2M 3.73%
229,680
-500
-0.2% -$72.3K
UNH icon
4
UnitedHealth
UNH
$377B
$25.1M 2.82%
49,974
+267
+0.5% +$121K
META icon
5
Meta Platforms (Facebook)
META
$1.5T
$24.2M 2.72%
72,025
+1,906
+3% +$633K
PFE icon
6
Pfizer
PFE
$143B
$23.4M 2.62%
395,802
+37,059
+10% +$1.84M
LOW icon
7
Lowe's Companies
LOW
$119B
$23.2M 2.6%
89,568
+417
+0.5% +$99.1K
JNJ icon
8
Johnson & Johnson
JNJ
$613B
$20.1M 2.25%
117,277
+3,039
+3% +$498K
JPM icon
9
JPMorgan Chase
JPM
$937B
$20M 2.25%
126,420
+1,761
+1% +$289K
AMZN icon
10
Amazon
AMZN
$3.06T
$19.5M 2.19%
116,980
+4,900
+4% +$839K
MCD icon
11
McDonald's
MCD
$188B
$17.8M 1.99%
66,246
+534
+0.8% +$135K
FDX icon
12
FedEx
FDX
$73.2B
$17.4M 1.96%
67,461
+5,480
+9% +$1.32M
NEE icon
13
NextEra Energy
NEE
$181B
$16.9M 1.9%
181,476
+1,279
+0.7% +$111K
BN icon
14
Brookfield
BN
$107B
$16.4M 1.84%
503,217
+7,522
+2% +$238K
PG icon
15
Procter & Gamble
PG
$338B
$15.6M 1.75%
95,454
-3,095
-3% -$460K
BRK.B icon
16
Berkshire Hathaway Class B
BRK.B
$1.11T
$15.6M 1.75%
52,106
+648
+1% +$186K
PEP icon
17
PepsiCo
PEP
$191B
$15.3M 1.72%
88,185
-685
-0.8% -$112K
CB icon
18
Chubb
CB
$134B
$15.2M 1.71%
78,885
+1,681
+2% +$316K
AMAT icon
19
Applied Materials
AMAT
$411B
$15M 1.68%
95,146
-2,526
-3% -$366K
SYK icon
20
Stryker
SYK
$131B
$14.3M 1.6%
53,389
-204
-0.4% -$53.5K
ABT icon
21
Abbott
ABT
$185B
$13.9M 1.56%
98,879
+1,704
+2% +$218K
CSCO icon
22
Cisco
CSCO
$457B
$13.8M 1.55%
217,380
+8,598
+4% +$491K
NKE icon
23
Nike
NKE
$63.3B
$13.5M 1.52%
81,274
-1,277
-2% -$211K
DIS icon
24
Walt Disney
DIS
$170B
$13.5M 1.52%
87,394
-1,418
-2% -$229K
TSN icon
25
Tyson Foods
TSN
$21B
$12.9M 1.44%
147,451
+3,224
+2% +$265K

Similar funds

Callahan Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Callahan Advisors held 153 positions worth $891M, up 12% from $794M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Callahan Advisors's Q4 2021 filing shows 7 new, 75 increased, 46 reduced and 5 closed positions. Its largest new stake was Paramount Global Class B: 53,775 shares worth $1.62M. The largest sale was Bristol-Myers Squibb, an estimated $1.75M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Callahan Advisors's largest Q4 2021 buy was Paramount Global Class B: 53,775 shares worth $1.62M.
  • Callahan Advisors added most to D.R. Horton in Q4 2021, an estimated $2.2M increase.
  • Callahan Advisors's biggest Q4 2021 reduction was Bristol-Myers Squibb, cutting an estimated $1.75M.
  • Callahan Advisors fully exited ANHEUSER BUSCH COS INC in Q4 2021, selling an estimated $1.33M.
  • Callahan Advisors's ten largest holdings make up 30% of its $891M portfolio in Q4 2021.
  • Callahan Advisors opened 7 new positions and closed 5 in Q4 2021.
  • Callahan Advisors's portfolio value rose 12% quarter-over-quarter to $891M.

Based on Callahan Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.